Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations section was updated to add new site listings across multiple states and countries (examples include Akita, Aomori, Kanagawa, Kyoto, Tokyo, New South Wales, and South Australia). Older location listings were removed.SummaryDifference2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2, a minor system version change with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded notes indicating that publications are automatically filled from PubMed and may not be about the study, and recorded Revision: v3.3.1. Removed the previous PubMed source wording and Revision: v3.2.0 tag.SummaryDifference0.1%

- Check49 days agoChange DetectedDeleted the notice about government funding and NIH operating status; operating-status information is no longer displayed.SummaryDifference0.2%

- Check63 days agoChange DetectedNo significant changes to core study details (eligibility criteria, primary outcomes, enrollment, locations) were observed; the differences seem limited to minor layout/format updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check92 days agoChange DetectedKey change: page now includes a government funding status notice and a current operating status update, plus a v3.2.0 release label replacing v3.1.0.SummaryDifference3%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.